- Home
- BBNX
as 08-01-2025 4:00pm EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 578.8M | IPO Year: | 2025 |
| Target Price: | $24.40 | AVG Volume (30 days): | 542.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.89 - $24.50 | Next Earning Date: | 07-29-2025 |
| Revenue: | $69,830,000 | Revenue Growth: | 38911.17% |
| Revenue Growth (this year): | 32.71% | Revenue Growth (next year): | 37.37% |
Latest Beta Bionics Inc. Common Stock News
BBNX Breaking Stock News: Dive into BBNX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
MedTech Dive
a month ago
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors
Zacks
a month ago
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
MedTech Dive
a month ago
5 things to watch at the ADA’s Scientific Sessions
GlobeNewswire
a month ago
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
Investing.com
2 months ago
Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth
MT Newswires
2 months ago
Truist Securities Initiates Beta Bionics at Buy With $26 Price Target
MedTech Dive
2 months ago
Beta Bionics CEO, CFO on how to take a company public
Compare BBNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.